Cargando…

Active Surveillance for Localized Prostate Cancer – Current Practices and Recommendations

Prostate cancer is now the most commonly diagnosed solid tumor in American men, due in part to widespread screening and aggressive diagnostic practices. Prostate cancer autopsy studies show the uniquely high prevalence rates of small, indolent tumors in men dying of other causes. These findings have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jennifer N., Dall'Era, Marc A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763778/ https://www.ncbi.nlm.nih.gov/pubmed/21170486 http://dx.doi.org/10.1100/tsw.2010.227

Ejemplares similares

Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer
por: Glass, Allison S., et al.
Publicado: (2018)

Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016)

Active surveillance for prostate cancer
por: Dall’Era, Marc A., et al.
Publicado: (2018)

Defining the Optimal Management Strategy for Small Renal Masses
por: Dall’Era, Marc, et al.
Publicado: (2021)

Differential expression of CD10 in prostate cancer and its clinical implication
por: Dall'Era, Marc A, et al.
Publicado: (2007)

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project
por: Dall'Era, Maria C, et al.
Publicado: (2014)

Current status of active surveillance in prostate cancer
por: Chung, Mun Su, et al.
Publicado: (2016)

Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis
por: Yazdany, Jinoos, et al.
Publicado: (2014)

Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer
por: Parikh, Mamta, et al.
Publicado: (2021)

Active surveillance for prostate cancer: when to recommend delayed intervention
por: Babaian, Kara N
Publicado: (2015)

Active Surveillance for Prostate Cancer: Past, Current, and Future Trends
por: de Vos, Ivo I., et al.
Publicado: (2023)

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer()
por: Lombard, Alan P, et al.
Publicado: (2019)

Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice
por: Pastor-Navarro, Belén, et al.
Publicado: (2021)

Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
por: Blas, Leandro, et al.
Publicado: (2022)

Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome
por: Dall'Era, Maria, et al.
Publicado: (2015)

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era
por: Kim, Isaac E., et al.
Publicado: (2021)

Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA
por: Collins, C E, et al.
Publicado: (2016)

The current role of Active Surveillance in early prostate cancer
por: Shrinivas, R. P., et al.
Publicado: (2009)

Appraising risk in active surveillance of localized prostate cancer
por: Hogden, Anne, et al.
Publicado: (2019)

Expanded criteria for active surveillance in prostate cancer: a review of the current data
por: Jones, Cameron, et al.
Publicado: (2018)

Validation study of a computer-based open surgical trainer: SimPraxis(®) simulation platform
por: Tran, Linh N, et al.
Publicado: (2013)

Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices
por: Kinsella, Netty, et al.
Publicado: (2018)

Safety and efficacy of active surveillance in patients with localized prostate cancer
por: Mavuduru, Ravimohan, et al.
Publicado: (2008)

The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and Subtype
por: Monda, Steven M., et al.
Publicado: (2023)

Prostate cancer: a review of active surveillance
por: Lund, Lars, et al.
Publicado: (2014)

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer
por: Liu, Chengfei, et al.
Publicado: (2018)

Active surveillance for prostate cancer
por: Shill, Daniela K., et al.
Publicado: (2021)

Evidence-based recommendations on androgen deprivation therapy for localized and advanced prostate cancer
por: Golabek, Tomasz, et al.
Publicado: (2016)

Active surveillance for low-risk prostate cancer
por: Klotz, Laurence
Publicado: (2012)

The Role of MRI in Prostate Cancer Active Surveillance
por: Johnson, Linda M., et al.
Publicado: (2014)

Focal therapy for localized prostate cancer – Current status
por: Atluri, Shrikanth, et al.
Publicado: (2022)

Aggressive Prostate Cancer in Patients Treated with Active Surveillance
por: Tohi, Yoichiro, et al.
Publicado: (2023)

The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer
por: Numakura, Kazuyuki, et al.
Publicado: (2023)

First brazilian consensus of advanced prostate cancer: recommendations for clinical practice
por: Sasse, Andre Deeke, et al.
Publicado: (2017)

Testosterone for the aging male; current evidence and recommended practice
por: Stanworth, Roger D, et al.
Publicado: (2008)

Focal therapy for localized prostate cancer: is there a “middle ground” between active surveillance and definitive treatment?
por: Demirel, Cihan H, et al.
Publicado: (2019)

Survey on the practice of active surveillance for prostate cancer from the Middle East
por: El Sebaaly, Ralph, et al.
Publicado: (2020)

Current concepts in multiparametric magnetic resonance imaging for active surveillance of prostate cancer
por: Cavalcante, Alexandre, et al.
Publicado: (2018)

Applying precision medicine to the active surveillance of prostate cancer
por: Reichard, Chad A., et al.
Publicado: (2015)

Racial disparities and considerations for active surveillance of prostate cancer
por: Jiang, Song, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vqmv527eqs4bjoqldm5cr122ls